PDS Biotech Announces Expansion of its VERSATILE-002 Clinical Trial into Europe
Go back to PDS Biotech Announces Expansion of its VERSATILE-002 Clinical Trial into Europe| (NASDAQ: PDSB) | Delayed: 0.75 -0.02 (2.6%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.77 | 52 Week High | $ | |||
| Open | $0.77 | 52 Week Low | $ | |||
| Day High | $0.79 | P/E | N/A | |||
| Day Low | $0.73 | EPS | $ | |||
| Volume | 324,140 | |||||

